A 68-year-old patient with type 2 diabetes is scheduled for a contrast-enhanced CT of the abdomen. The patient's medication list includes Metformin. Their most recent lab results show an eGFR of 50 mL/min/1.73 m². Based on the Canadian Association of Radiologists (CAR) guidelines, what is the most appropriate action regarding the Metformin?
-
A
Instruct the patient to stop taking Metformin 48 hours before the scan.
-
B
Proceed with the scan and instruct the patient to continue taking Metformin as prescribed.
-
C
Administer a lower dose of contrast media and stop Metformin for 24 hours.
-
D
Consult the radiologist to consider an alternative imaging modality not requiring contrast.